Fig. 5From: Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY studya Success rate of early combination and initial monotherapy approaches at cut-off HbA1c 7.0%. HbA1c glycated hemoglobin. b Success rate of early combination and initial monotherapy approaches at cut-off HbA1c 6.5%. HbA1c, glycated hemoglobin. c Success rate of early combination and initial monotherapy approaches at cut-off HbA1c 6.0%. HbA1c glycated hemoglobinBack to article page